Literature DB >> 22466657

The immunology of neurodegeneration.

Eva Czirr1, Tony Wyss-Coray.   

Abstract

While immune responses in neurodegeneration were regarded as little more than a curiosity a decade ago, they are now increasingly moving toward center stage. Factors driving this movement include the recognition that most of the relevant immune molecules are produced within the brain, that microglia are proficient immune cells shaping neuronal circuitry and fate, and that systemic immune responses affect brain function. We will review this complex field from the perspective of neurons, extra-neuronal brain cells, and the systemic environment and highlight the possibility that cell intrinsic innate immune molecules in neurons may function in neurodegenerative processes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466657      PMCID: PMC3315444          DOI: 10.1172/JCI58656

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  124 in total

1.  Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery.

Authors:  M F Newman; J L Kirchner; B Phillips-Bute; V Gaver; H Grocott; R H Jones; D B Mark; J G Reves; J A Blumenthal
Journal:  N Engl J Med       Date:  2001-02-08       Impact factor: 91.245

2.  NSAIDs and incident Alzheimer's disease. The Rotterdam Study.

Authors:  B A in 't Veld; L J Launer; A W Hoes; A Ott; A Hofman; M M Breteler; B H Stricker
Journal:  Neurobiol Aging       Date:  1998 Nov-Dec       Impact factor: 4.673

Review 3.  Can autophagy protect against neurodegeneration caused by aggregate-prone proteins?

Authors:  Brinda Ravikumar; David C Rubinsztein
Journal:  Neuroreport       Date:  2004-11-15       Impact factor: 1.837

Review 4.  Toll-like receptor signaling in neural plasticity and disease.

Authors:  Eitan Okun; Kathleen J Griffioen; Mark P Mattson
Journal:  Trends Neurosci       Date:  2011-03-16       Impact factor: 13.837

5.  Modeling of pathological traits in Alzheimer's disease based on systemic extracellular signaling proteome.

Authors:  Markus Britschgi; Kaspar Rufibach; Sarah L Bauer Huang; Christopher M Clark; Jeffrey A Kaye; Ge Li; Elaine R Peskind; Joseph F Quinn; Douglas R Galasko; Tony Wyss-Coray
Journal:  Mol Cell Proteomics       Date:  2011-07-08       Impact factor: 5.911

6.  Depletion of CXCR2 inhibits γ-secretase activity and amyloid-β production in a murine model of Alzheimer's disease.

Authors:  Pancham Bakshi; Elaina Margenthaler; Jon Reed; Fiona Crawford; Michael Mullan
Journal:  Cytokine       Date:  2010-11-16       Impact factor: 3.861

7.  Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease.

Authors:  Krishnan Sriram; Joanna M Matheson; Stanley A Benkovic; Diane B Miller; Michael I Luster; James P O'Callaghan
Journal:  FASEB J       Date:  2002-07-18       Impact factor: 5.191

8.  Rate of cell death in parkinsonism indicates active neuropathological process.

Authors:  P L McGeer; S Itagaki; H Akiyama; E G McGeer
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

9.  Toll-like receptor 4 is a sensor for autophagy associated with innate immunity.

Authors:  Yi Xu; Chinnaswamy Jagannath; Xian-De Liu; Amir Sharafkhaneh; Katarzyna E Kolodziejska; N Tony Eissa
Journal:  Immunity       Date:  2007-07-19       Impact factor: 31.745

10.  Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.

Authors:  J Sanchez-Ramos; S Song; V Sava; B Catlow; X Lin; T Mori; C Cao; G W Arendash
Journal:  Neuroscience       Date:  2009-06-14       Impact factor: 3.590

View more
  100 in total

1.  Lessons learned at the intersection of immunology and neuroscience.

Authors:  Lawrence Steinman
Journal:  J Clin Invest       Date:  2012-04-02       Impact factor: 14.808

Review 2.  Sorting through the roles of beclin 1 in microglia and neurodegeneration.

Authors:  Caitlin E O'Brien; Tony Wyss-Coray
Journal:  J Neuroimmune Pharmacol       Date:  2014-01-03       Impact factor: 4.147

Review 3.  Inflammasomes in the CNS.

Authors:  John G Walsh; Daniel A Muruve; Christopher Power
Journal:  Nat Rev Neurosci       Date:  2014-01-08       Impact factor: 34.870

Review 4.  Innate immune responses regulate morphogenesis and degeneration: roles of Toll-like receptors and Sarm1 in neurons.

Authors:  Hsin-Yu Liu; Chiung-Ya Chen; Yi-Ping Hsueh
Journal:  Neurosci Bull       Date:  2014-07-04       Impact factor: 5.203

Review 5.  Harnessing Immunoproteostasis to Treat Neurodegenerative Disorders.

Authors:  Todd E Golde
Journal:  Neuron       Date:  2019-03-20       Impact factor: 17.173

Review 6.  TREM2-Ligand Interactions in Health and Disease.

Authors:  Daniel L Kober; Tom J Brett
Journal:  J Mol Biol       Date:  2017-04-19       Impact factor: 5.469

7.  Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging.

Authors:  Yun-Hee Youm; Ryan W Grant; Laura R McCabe; Diana C Albarado; Kim Yen Nguyen; Anthony Ravussin; Paul Pistell; Susan Newman; Renee Carter; Amanda Laque; Heike Münzberg; Clifford J Rosen; Donald K Ingram; J Michael Salbaum; Vishwa Deep Dixit
Journal:  Cell Metab       Date:  2013-10-01       Impact factor: 27.287

8.  Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions.

Authors:  Stephanie C Joachim; Christine Mondon; Oliver W Gramlich; Franz H Grus; H Burkhard Dick
Journal:  J Mol Neurosci       Date:  2013-10-03       Impact factor: 3.444

Review 9.  Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.

Authors:  Paul C Trippier; Kristin Jansen Labby; Dustin D Hawker; Jan J Mataka; Richard B Silverman
Journal:  J Med Chem       Date:  2013-03-27       Impact factor: 7.446

10.  Dnr1 mutations cause neurodegeneration in Drosophila by activating the innate immune response in the brain.

Authors:  Yang Cao; Stanislava Chtarbanova; Andrew J Petersen; Barry Ganetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.